Correction to: An update on the CNS manifestations of neurofibromatosis type 2

Shannon Coy; Rumana Rashid; Anat Stemmer-Rachamimov; Sandro Santagata

doi:10.1007/s00401-019-02044-6

Correction to: An update on the CNS manifestations of neurofibromatosis type 2

Acta Neuropathol. 2020 Apr;139(4):667. doi: 10.1007/s00401-019-02044-6.

Authors

Shannon Coy^{1

2

3}, Rumana Rashid^{1

3

4}, Anat Stemmer-Rachamimov^{3

5}, Sandro Santagata^{6

7

8

9

10}

Affiliations

¹ Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Hale Building for Transformative Medicine, BTM8002P, 60 Fenwood Road, Boston, MA, 02115, USA.
² Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
³ Harvard Medical School, Boston, MA, USA.
⁴ Laboratory for Systems Pharmacology, Harvard Program in Therapeutic Science, Boston, MA, USA.
⁵ Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
⁶ Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Hale Building for Transformative Medicine, BTM8002P, 60 Fenwood Road, Boston, MA, 02115, USA. ssantagata@bics.bwh.harvard.edu.
⁷ Department of Pathology, Boston Children's Hospital, Boston, MA, USA. ssantagata@bics.bwh.harvard.edu.
⁸ Harvard Medical School, Boston, MA, USA. ssantagata@bics.bwh.harvard.edu.
⁹ Laboratory for Systems Pharmacology, Harvard Program in Therapeutic Science, Boston, MA, USA. ssantagata@bics.bwh.harvard.edu.
¹⁰ Ludwig Center at Harvard, Boston, MA, USA. ssantagata@bics.bwh.harvard.edu.

Abstract

The article An update on the CNS manifestations of neurofibromatosis type 2, written by Shannon Coy, Rumana Rashid, Anat Stemmer‑Rachamimov and Sandro Santagata, was originally published electronically on the publisher's internet portal (currently SpringerLink) on 04 June 2019 without open access.

Publication types

Published Erratum